Synthesis of Cddo-Amino Acid-Nitric Oxide Donor Trihybrids As Potential Antitumor Agents Against Both Drug-Sensitive and Drug-Resistant Colon Cancer
Yong Ai,Fenghua Kang,Zhangjian Huang,Xiaowen Xue,Yisheng Lai,Sixun Peng,Jide Tian,Yihua Zhang
DOI: https://doi.org/10.1021/jm5019302
IF: 8.039
2015-01-01
Journal of Medicinal Chemistry
Abstract:Seventeen CDDO-amino acid-NO donor trihybrids (4a-q) were designed and synthesized. Biological evaluation indicated that the most active compound 4c produced high levels of NO and inhibited the proliferation of drug-sensitive (HCT-8, IC50 = 0.294 μM) and drug-resistant (HCT-8/5-FU, IC50 = 0.232 μM) colon cancer cells, which were attenuated by an NO scavenger or typical substrate of PepT1. Furthermore, 4c triggered HCT-8 and HCT-8/5-FU cell apoptosis more strongly than CDDO-Me, inhibited the HIF-1α, Stat3, AKT, and ERK signaling, and induced the nitration of P-gp, MRP1, and BCRP proteins in HCT-8/5-FU cells. Finally, 4c had 4.36-5.53-fold less inhibitory activity against nontumor colon epithelial-like cells (CCD841, IC50 = 1.282 μM) in vitro and inhibited the growth of implanted human drug-resistant colon cancers in mice more potently than CDDO-Me. Together, 4c is a novel trihybrid with potent antitumor activity and may be a promising candidate for the treatment of drug-resistant colon cancer.